Annual General Meeting in ALK-Abelló A/S on 14 March 2024
16 févr. 2024 08h00 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 14 March 2024 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm,...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
12 févr. 2024 10h15 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12 févr. 2024 10h15 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
12 févr. 2024 05h30 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12 févr. 2024 05h30 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Annual report 2023: ALK delivers 9% sales growth with profits up 50%
08 févr. 2024 07h35 HE
|
ALK Abello
08 February 2024 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in line with the...
ALK and McMaster researchers discover new cell that remembers allergies
07 févr. 2024 14h10 HE
|
ALK Abello
Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abelló A/S have made a ground-breaking discovery: a new cell that remembers allergies. The discovery gives...
ALK’s 2030 CO2 reduction targets have been approved by SBTi
05 févr. 2024 03h30 HE
|
ALK Abello
ALK’s near-term carbon reduction targets for scope 1, 2 and 3 have been validated and approved by the Science Based Targets initiative. Today, ALK announces that its near-term carbon reduction...
Dato for offentliggørelse af årsrapport for 2023 for ALK og webcast
31 janv. 2024 03h44 HE
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør årsrapport for 2023 torsdag den 8. februar 2024 om eftermiddagen. ALK afholder samme dag kl. 16.00 (CET) en telekonference for investorer og...
Release date of annual report 2023 for ALK and webcast
31 janv. 2024 03h44 HE
|
ALK Abello
On Thursday, 8 February 2024 in the afternoon, ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its annual report for 2023. ALK will host an online meeting for analysts and institutional investors...